Remote Ischemic Conditioning (CPB 0814, reviewed 2025-11-20)
Aetna's Clinical Policy Bulletin 0814 considers remote ischemic conditioning experimental, investigational, or unproven for many indications because its effectiveness has not been established. The listed indications include acute coronary syndromes in individuals undergoing percutaneous coronary intervention, prevention of contrast-induced acute kidney injury, improvement of outcomes in individuals with acute ischemic stroke undergoing intravenous thrombolysis, improvement of outcomes following orthopedic surgery, sepsis management, and treatment of ulcerative colitis. The bulletin states that there are no specific codes for remote ischemic conditioning.